Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

COVID-19 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 289enzalutamide 283Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 252Abiraterone Acetate 217Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 117Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 106cabozantinib 104atezolizumab 104Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pandemic Preparedness × Genitourinary × Clear all
NCT05083143 2022-04-27

The Impact of the COVID-19 Pandemic on Testicular Cancer

Ankara Training and Research Hospital

Completed
50 enrolled
Genitourinary

COVID-19, Testicular Neoplasms

NCT04900259 2021-10-06

The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations

Ankara Training and Research Hospital

Completed
183 enrolled
Genitourinary

COVID-19, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡